Home » Newsletters » BioWorld

BioWorld

Jan. 27, 2009

View Archived Issues

Biotech Reveling in the Stem Cell Effect, Embryonic or not

It's never been so good to be working in the embryonic stem cell space. (BioWorld Today) Read More

Pfizer $68B Bid for Wyeth Leaves Crucell at the Altar

Nearly a Decade Later, RECIST Rules Get Their First Makeover

Investors Balk as Altus Drops Trizytek and Cuts 75% of Staff

Forma Getting up to $54M in Cubist Antibacterial Deal

AC Immune Gets $35M for Alzheimer's Pipeline

Other News To Note

Clinic Roundup

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...